Top Markets
Coin of the day
Defence Therapeutics Inc. Defence Therapeutics Inc.

Defence Therapeutics Inc.

DTC
Rang in Aktien #28131
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Aktienkurs
$0.37430781
Zuletzt synchronisiert: 2026-08-19
Marktkapitalisierung
$28.37M
Veränderung (1 Tag)
2.00%
Veränderung (1 Jahr)
-13.46%
Land
CA
Handel Defence Therapeutics Inc. (DTC)

Kategorie

Kursverlauf für Defence Therapeutics Inc. (DTC)
Höchster Schlusskurs: $0.32 am 2026-08-01

Niedrigster Schlusskurs: $2.94 am 2021-05-01
Kursverlauf der Aktie von Defence Therapeutics Inc. von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -20.25%
2025 47.28%
2024 -78.72%
2023 11.75%
2022 -62.63%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$122.11 -14.02%
AU
$753.28 5.84%
CH